| Code | 2735A | ||||||||||
| MA number | 58/0419/12-S | ||||||||||
| Product Form: | tbl flm 180x40 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | blister PVC/PE/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.09.2012 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Valsartan Krka 40 mg_07_2021.pdf
|
| PIL: |
PIL_Valsartan Krka 40 mg_07_2021.pdf
|
| Safety feature | Yes |
| Data update: | 11.06.2020 |
